Total Payments
$1,421
2024 Payments
$103.88
Companies
17
Transactions
66
Medicare Patients
1,123
Medicare Billing
$697,108
Payment Breakdown by Category
Food & Beverage$1,401 (98.6%)
Education$19.69 (1.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,401 | 65 | 98.6% |
| Education | $19.69 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $279.46 | 15 | $0 (2022) |
| Relypsa, Inc. | $234.43 | 12 | $0 (2019) |
| Medline Industries, Inc. | $117.68 | 2 | $0 (2019) |
| Keryx Biopharmaceuticals, Inc. | $101.99 | 5 | $0 (2017) |
| Fresenius USA Marketing, Inc. | $99.58 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $93.28 | 1 | $0 (2017) |
| Mallinckrodt Enterprises LLC | $85.98 | 3 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $83.63 | 5 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $64.69 | 4 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $49.72 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $103.88 | 5 | Ardelyx, Inc. ($25.93) |
| 2023 | $21.43 | 1 | AstraZeneca Pharmaceuticals LP ($21.43) |
| 2022 | $119.87 | 6 | Amgen Inc. ($42.80) |
| 2021 | $15.90 | 1 | Amgen Inc. ($15.90) |
| 2020 | $33.65 | 2 | Mallinckrodt Hospital Products Inc. ($20.23) |
| 2019 | $455.74 | 18 | Relypsa, Inc. ($172.70) |
| 2018 | $221.94 | 12 | Amgen Inc. ($127.98) |
| 2017 | $448.48 | 21 | Keryx Biopharmaceuticals, Inc. ($101.99) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Cardio-renal | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | Fresenius USA Marketing, Inc. | CRIT-LINE (Device) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: System, Hemodialysis, Access Recirculation Monitoring | ||||||
| 03/27/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/24/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/05/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Education | In-kind items and services | $19.69 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/05/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/14/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/27/2022 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Nephrology | ||||||
| 03/03/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Cardio-renal | ||||||
| 02/10/2022 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Nephrology | ||||||
| 10/29/2021 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Nephrology | ||||||
| 01/29/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: NEPHROLOGY | ||||||
| 01/22/2020 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Hyperkalemia | ||||||
| 12/05/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug), JYNARQUE | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: NEPHROLOGY | ||||||
| 11/20/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 11/07/2019 | Medline Industries, Inc. | — | Food and Beverage | In-kind items and services | $110.32 | General |
| 11/07/2019 | Medline Industries, Inc. | — | Food and Beverage | In-kind items and services | $7.36 | General |
| 10/16/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $33.99 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 10/02/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Hyperkalemia | ||||||
| 10/02/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: Hyperkalemia | ||||||
| 09/03/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/28/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Hyperkalemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 110 | 524 | $155,908 | $89,060 |
| 2022 | 8 | 222 | 947 | $232,552 | $137,653 |
| 2021 | 11 | 346 | 1,397 | $379,113 | $221,965 |
| 2020 | 11 | 445 | 1,881 | $479,025 | $248,430 |
Total Patients
1,123
Total Services
4,749
Medicare Billing
$697,108
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 29 | 255 | $112,965 | $68,308 | 60.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 107 | $12,198 | $6,384 | 52.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 62 | $10,540 | $5,670 | 53.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 43 | $13,674 | $5,489 | 40.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 11 | 33 | $3,795 | $1,770 | 46.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 11 | 24 | $2,736 | $1,438 | 52.6% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 36 | 320 | $141,760 | $91,837 | 64.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 34 | 341 | $38,874 | $19,712 | 50.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 40 | 71 | $22,578 | $11,261 | 49.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 55 | $9,350 | $5,082 | 54.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 24 | 67 | $7,705 | $3,972 | 51.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 30 | 59 | $6,726 | $3,442 | 51.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $4,369 | $1,789 | 40.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 17 | $1,190 | $558.03 | 46.9% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 49 | 464 | $205,552 | $137,383 | 66.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 13 | 135 | $58,860 | $24,709 | 42.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 51 | 387 | $44,118 | $22,907 | 51.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 57 | 85 | $27,030 | $14,022 | 51.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 68 | $11,560 | $7,023 | 60.8% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 29 | 103 | $11,845 | $6,194 | 52.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 55 | 87 | $9,918 | $5,158 | 52.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $3,855 | $1,908 | 49.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 12 | 15 | $4,275 | $1,508 | 35.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 22 | $1,540 | $926.00 | 60.1% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 14 | 16 | $560.00 | $226.51 | 40.4% |
About Dr. Deon Middlebrook, MD
Dr. Deon Middlebrook, MD is a Nephrology healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508898123.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deon Middlebrook, MD has received a total of $1,421 in payments from pharmaceutical and medical device companies, with $103.88 received in 2024. These payments were reported across 66 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,401).
As a Medicare-enrolled provider, Middlebrook has provided services to 1,123 Medicare beneficiaries, totaling 4,749 services with total Medicare billing of $697,108. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Specialist
- Location Detroit, MI
- Active Since 07/06/2006
- Last Updated 09/14/2023
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1508898123
Products in Payments
- Veltassa (Drug) $234.43
- Parsabiv (Biological) $184.57
- ACTHAR (Biological) $106.21
- Auryxia (Drug) $101.99
- ENTRESTO (Drug) $93.28
- Velphoro (Drug) $80.14
- Parsabiv (Drug) $58.70
- FARXIGA (Drug) $51.43
- SAMSCA (Drug) $51.27
- Kerendia (Drug) $49.72
- RENVELA (Drug) $47.60
- LUPKYNIS (Drug) $38.85
- Sensipar (Drug) $36.19
- Renal - Revaclear (Device) $26.10
- IBSRELA (Drug) $25.93
- CRIT-LINE (Device) $19.44
- Renal - HD (Device) $18.88
- SYMBICORT (Drug) $17.43
- Ozempic (Drug) $17.01
- Rayaldee (Drug) $15.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Detroit
Kausik Umanath, Md, Ms, MD, MS
Nephrology — Payments: $188,476
Nephrology $188,476
Anatole Besarab, M.d, M.D
Nephrology — Payments: $102,122
Nephrology $102,122
Dr. Aris Urbanes, Md, MD
Nephrology — Payments: $24,392
Nephrology $24,392
Anita Patel, M.d, M.D
Nephrology — Payments: $6,142
Nephrology $6,142
Dr. Nashat Imran, M.d, M.D
Nephrology — Payments: $3,101
Nephrology $3,101
Dr. Naveed Haq, Md, MD
Nephrology — Payments: $2,536
Nephrology $2,536